Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

Roxane Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ROXANE, and what generic and branded alternatives to ROXANE drugs are available?

ROXANE has one hundred and twenty-eight approved drugs.

Summary for Roxane

US Patents:	0
Tradenames:	74
Ingredients:	67
NDAs:	128
Patent Litigation for Roxane:	See patent lawsuits for Roxane
PTAB Cases with Roxane as petitioner:	See PTAB cases with Roxane as petitioner

Drugs and US Patents for Roxane

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roxane	THIORIDAZINE HYDROCHLORIDE INTENSOL	thioridazine hydrochloride	CONCENTRATE;ORAL	088942-001	Dec 16, 1985		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Roxane	THIORIDAZINE HYDROCHLORIDE	thioridazine hydrochloride	TABLET;ORAL	088664-001	Mar 15, 1984		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Roxane	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	085945-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Roxane	ISOETHARINE HYDROCHLORIDE	isoetharine hydrochloride	SOLUTION;INHALATION	088275-001	Jun 3, 1983		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Roxane	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077223-001	Jul 2, 2007		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Roxane

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Dow

Harvard Business School

Johnson and Johnson

McKesson

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.